Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Minnesota |
---|---|
Information provided by: | University of Minnesota |
ClinicalTrials.gov Identifier: | NCT00269594 |
The goal of the proposed study is to evaluate the efficacy and safety of Lamictal in neurotic excoriation. Twenty subjects with neurotic excoriation will receive 12 weeks of open-label treatment with Lamictal. The hypothesis to be tested is that Lamictal will be effective and well tolerated in patients with neurotic excoriation. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.
Condition | Intervention | Phase |
---|---|---|
Neurotic Disorders Obsessive-Compulsive Disorder |
Drug: Lamictal (lamotrigine) |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | An Open-Label Study of Lamictal In Neurotic Excoriation |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Minnesota | |
University of Minnesota | |
Minneapolis, Minnesota, United States, 55454 |
Principal Investigator: | Jon E Grant, JD, MD | University of Minnesota |
Study ID Numbers: | 0510M77009 |
Study First Received: | December 22, 2005 |
Last Updated: | April 27, 2007 |
ClinicalTrials.gov Identifier: | NCT00269594 |
Health Authority: | United States: Institutional Review Board |
Skin Picking Pick Neurotic Excoriation |
Calcium, Dietary Skin Diseases Anxiety Disorders Mental Disorders Neurotic Disorders |
Lamotrigine Obsessive-Compulsive Disorder Behavioral Symptoms Self-Injurious Behavior Dermatitis |
Membrane Transport Modulators Pathologic Processes Disease Molecular Mechanisms of Pharmacological Action Therapeutic Uses |
Calcium Channel Blockers Cardiovascular Agents Central Nervous System Agents Anticonvulsants Pharmacologic Actions |